BAMCO Inc
TXG icon

BAMCO Inc’s 10x Genomics TXG Stock Holding History

BAMCO Inc’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-314,862
Closed -$6.12M – 343
2024
Q2 		$6.12M Hold
314,862
– – 0.02% 254
2024
Q1 		$11.8M Buy
314,862
+117,300
+59% +$5.15M 0.03% 235
2023
Q4 		$11.1M Buy
197,562
+16,636
+9% +$724K 0.03% 228
2023
Q3 		$7.46M Buy
180,926
+153,300
+555% +$7.97M 0.02% 244
2023
Q2 		$1.54M Buy
27,626
+8,226
+42% +$445K ﹤0.01% 300
2023
Q1 		$1.08M Hold
19,400
– – ﹤0.01% 320
2022
Q4 		$707K Sell
19,400
-295,879
-94% -$9.67M ﹤0.01% 341
2022
Q3 		$8.98M Sell
315,279
-90,676
-22% -$3.45M 0.03% 242
2022
Q2 		$18.4M Buy
405,955
+38,672
+11% +$2.01M 0.06% 214
2022
Q1 		$27.9M Sell
367,283
-232,691
-39% -$20.4M 0.07% 198
2021
Q4 		$89.4M Buy
599,974
+15,890
+3% +$2.43M 0.19% 95
2021
Q3 		$85M Sell
584,084
-2,965
-0.5% -$509K 0.19% 103
2021
Q2 		$115M Sell
587,049
-7,709
-1% -$1.4M 0.26% 82
2021
Q1 		$108M Sell
594,758
-2,124
-0.4% -$367K 0.27% 82
2020
Q4 		$84.5M Buy
596,882
+109,845
+23% +$15.9M 0.21% 101
2020
Q3 		$60.7M Buy
487,037
+63,332
+15% +$6.65M 0.19% 111
2020
Q2 		$37.8M Buy
423,705
+196,185
+86% +$15.3M 0.14% 128
2020
Q1 		$14.2M Buy
227,520
+76,388
+51% +$5.96M 0.07% 174
2019
Q4 		$11.5M Buy
151,132
+532
+0.4% +$32K 0.04% 204
2019
Q3 		$7.59M Buy
+150,600
New +$8.33M 0.03% 228

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BAMCO Inc's TXG Position: Q3 2024 in Review

BAMCO Inc sold out of 10x Genomics (TXG) in Q3 2024, closing a stake of 314,862 shares — an estimated $6.12M sold.

BAMCO Inc first reported a position in TXG in Q3 2019 and held it in 20 quarters. The position peaked at $115M in Q2 2021. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

  • BAMCO Inc reported no remaining 10x Genomics position as of Q3 2024 after selling out during the quarter.
  • BAMCO Inc sold 314,862 10x Genomics shares in Q3 2024, an estimated $6.12M.
  • BAMCO Inc first reported a position in 10x Genomics in Q3 2019 and held it in 20 quarters.
  • BAMCO Inc's 10x Genomics position peaked at $115M in Q2 2021.
  • 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on BAMCO Inc's 13F filing for Q3 2024, filed 14 Nov 2024.